2019
DOI: 10.1177/1526602819863081
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes From the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease

Abstract: Purpose: To report the results of endovascular treatment of iliac and complex aortoiliac occlusive disease (AIOD) in a multicenter Italian registry. Materials and Methods: A retrospective, multicenter, observational cohort study analyzed 713 patients (mean age 68±10 years; 539 men) with isolated iliac and complex aortoiliac lesions treated with primary stenting between January 2015 and December 2017. Indications for treatment were claudication in 406 (57%) patients and critical limb ischemia in 307 (43%). Acco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

3
23
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 34 publications
3
23
0
3
Order By: Relevance
“…According to the TASC II guidelines, open surgery remains the gold standard of treatment for complex aortoiliac disease because it has excellent short-and longterm patency rates, which are as high as 85-92% [11,16,17]. The primary 2-year patency rate for complex and extensive lesions treated with endovascular procedures was 94% in one multicenter study, which is comparable to the outcomes of TASC A and B lesions [18]. Even the long-term outcomes of stent placement in complex aortoiliac CTOs are acceptable, such as the 5-year patency rate of 88% found in the study conducted by Ichihashi et al [19].…”
Section: Discussionmentioning
confidence: 81%
“…According to the TASC II guidelines, open surgery remains the gold standard of treatment for complex aortoiliac disease because it has excellent short-and longterm patency rates, which are as high as 85-92% [11,16,17]. The primary 2-year patency rate for complex and extensive lesions treated with endovascular procedures was 94% in one multicenter study, which is comparable to the outcomes of TASC A and B lesions [18]. Even the long-term outcomes of stent placement in complex aortoiliac CTOs are acceptable, such as the 5-year patency rate of 88% found in the study conducted by Ichihashi et al [19].…”
Section: Discussionmentioning
confidence: 81%
“…According to the TASC II guidelines, open surgery remains the gold standard of treatment for complex aortoiliac disease because it has excellent short-and long-term patency rates, which are as high as 85%-92% [11,16,17]. The primary 2-year patency rate for complex and extensive lesions treated with endovascular procedures was 94% in one multicenter study, which is comparable to the outcomes of TASC A and B lesions [18]. Even the long-term outcomes of stent placement in complex aortoiliac CTOs are acceptable, such as the 5-year patency rate of 88% found in the study conducted by Ichihashi et al [19].…”
Section: Discussionmentioning
confidence: 84%
“…According to the TASC II guidelines, open surgery remains the gold standard of treatment for complex aortoiliac disease because it has excellent short-and long-term patency rates, which are as high as 85%-92% [11,16,17]. The primary 2-year patency rate for complex and extensive lesions treated with endovascular procedures was 94% in one multicenter study, which is comparable to the outcomes of TASC A and B lesions [18]. Even the long-term outcomes of stent placement in complex aortoiliac CTOs are acceptable, such as the 5-year patency rate of 88% found in the study conducted by Ichihashi et al [19].…”
Section: Discussionmentioning
confidence: 84%